SLFN11 expression is also strongly correlated with the expression of CD47, a cell surface marker that sensitizes cancer cells to chemotherapy and radiotherapy, in RCC [86], while exogenous SLFN11 overexpression sensitizes CD47 negative cancer cells to radiotherapy [86]. Here, CD47 is linked to cancer.